The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Porembskaya O.Ya.
Mechnikov North-Western State Medical University;
Institute of Experimental Medicine
Kravchuk V.N.
Mechnikov North-Western State Medical University;
Kirov Military Medical Academy
Kuzmina-Krutetskaya S.R.
Mechnikov North-Western State Medical University
Laberko L.A.
Pirogov Russian National Research Medical University
Chesnokov M.Sh.
Mechnikov North-Western State Medical University
Velikanova K.E.
Mechnikov North-Western State Medical University
Saiganov S.A.
Mechnikov North-Western State Medical University
Pulmonary artery thrombosis: strategy of anticoagulation
Journal: Pirogov Russian Journal of Surgery. 2021;(11): 76‑82
Views: 2532
Downloaded: 79
To cite this article:
Porembskaya OYa, Kravchuk VN, Lobastov KV, et al. . Pulmonary artery thrombosis: strategy of anticoagulation. Pirogov Russian Journal of Surgery.
2021;(11):76‑82. (In Russ.)
https://doi.org/10.17116/hirurgia202111176
This review is devoted to the management of primary artery thrombosis (PAT). This disease was always considered only as a part of other venous thromboembolic events, in particular isolated pulmonary embolism (PE). Various studies show that PAT can develop as an independent event without concomitant damage to extra-vessels. PAT is characterized by own typical signs as primary and recurrent event that can determine special strategies of treatment. However, there are no studies devoted to this problem. We can only make some assumptions about PAT anticoagulation (AC) considering data on isolated PE comprising PAT. These data are available in PADIS-PE, ASPIRE, EINSTEIN-PE, Hokusai-VTE studies underlying modern guidelines of various societies. In the absence of studies on PAT AC these guidelines should regulate PAT AC approaches. AC is recommended in all cases of PE except isolated subsegmental PAT in ambulatory patients. Duration of AC depends on risk factors (major or minor). Anticoagulation for PAT following chronic inflammatory diseases is still disputable.
Authors:
Porembskaya O.Ya.
Mechnikov North-Western State Medical University;
Institute of Experimental Medicine
Kravchuk V.N.
Mechnikov North-Western State Medical University;
Kirov Military Medical Academy
Kuzmina-Krutetskaya S.R.
Mechnikov North-Western State Medical University
Laberko L.A.
Pirogov Russian National Research Medical University
Chesnokov M.Sh.
Mechnikov North-Western State Medical University
Velikanova K.E.
Mechnikov North-Western State Medical University
Saiganov S.A.
Mechnikov North-Western State Medical University
Received:
28.12.2020
Accepted:
02.03.2021
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.